Cancer Therapy Could Benefit from Chitosan-Based Nano-Prodrugs - AZoNano

Recently, a group of researchers has developed dynamic carboxymethyl chitosan (CMCS)-based nano-prodrugs crosslinked by water-soluble synergistic prodrug that is highly effective for selective chemotherapy.

Scientists have stated that polysaccharide-based nano-prodrug crosslinked by stimuli-responsive synergetic prodrugs exhibit great tumor selectivity, stability, and synergetic effect. As a result, suc… [+6382 chars]

full article...